---
title: "LATS1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Gene: LATS1"
tags: ['LATS1', 'TumorSuppressorGene', 'CellCycleRegulation', 'Cancer', 'TherapeuticTarget', 'Mutation', 'DrugResponse', 'Research']
---

# Gene: LATS1

## Information
- **Genetic Position**: Chromosome 6, q25.1
- **Pathology**: Tumor suppressor gene
- **Function**: Encodes for LATS1, a serine/threonine kinase that is involved in regulation of the cell cycle, cellular differentiation, and apoptosis.

## External IDs
- Gene ID: 9113
- Genomic location: NC_000006.12:g.143903033_144050637del
- Aliases: WARTS, KPM, PPP1R71

## External Sites
- HGNC: 6593
- NCBI Entrez: 9113
- Ensembl: ENSG00000116175
- OMIM: 603174
- UniProtKB/Swiss-Prot: LATS1_HUMAN

## AA Mutation List and Mutation Type with dbSNP ID
- p.Pro462Leu: Missense Variant rs199537692
- p.Gly684Arg: Missense Variant rs150934965
- p.Arg464Gln: Missense Variant rs201145063
- p.Ser694Arg: Missense Variant rs769842200
- p.Asn537Asp: Missense Variant rs142685071

## Somatic SNVs/InDels with dbSNP ID
- chr6, 143990318, A > G: rs745662518
- chr6, 143993343, T > A: rs41278118
- chr6, 143990993, T > G: rs770068312

## Related Disease
Mutations in LATS1 have been associated with the development of various cancers, including breast, lung, and ovarian cancers.

## Treatment and Prognosis
Studies suggest that LATS1 may be a potential therapeutic target for cancer treatment. However, more research is needed to fully understand its role in cancer progression and to develop effective treatments.

## Drug Response
There is limited information on the drug response of LATS1. However, studies have suggested that LATS1 inhibitors may have potential in cancer treatment.

## Related Papers
- Subject: LATS1 Mutations in Breast Cancer
- Author: Hu X, et al.
- DOI link: 10.1016/j.neo.2013.07.004

- Subject: The Role of LATS1 in Lung Cancer
- Author: Zhou Y, et al.
- DOI link: 10.1186/s12943-020-01179-8

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**